High prevalence of abnormal nocturnal oximetry in patients with hypertrophic cardiomyopathy.
about
Sleep-disordered breathing in hypertrophic cardiomyopathy: challenges and opportunities.Frequent periodic leg movement during sleep is associated with left ventricular hypertrophy and adverse cardiovascular outcomes.Decreased exercise capacity and sleep-disordered breathing in patients with hypertrophic cardiomyopathyRole of obstructive sleep apnea in cardiovascular disease.Prevalence, Severity, and Prognostic Value of Sleep Apnea Syndromes in Cardiac AmyloidosisLack of reliable clinical predictors to identify obstructive sleep apnea in patients with hypertrophic cardiomyopathy.Obstructive sleep apnea: novel trigger and potential therapeutic target for cardiac arrhythmias.Hypertrophic cardiomyopathy associated with sleep apnea: serious implications and cogent management strategy.Ameliorating the severity of sleep-disordered breathing concomitant with heart failure status after percutaneous transluminal septal myocardial ablation for drug-refractory hypertrophic obstructive cardiomyopathy.The hemodynamic impact of acute nasal continuous positive airway pressure treatment in hypertrophic cardiomyopathy: is it safe?Risk of glomerular filtration rate decline in patients with hypertrophic cardiomyopathy and obstructive sleep apnoea.Sleep-disordered breathing in children with cardiomyopathy.Incidence of sleep-disordered breathing in patients with hypertrophic cardiomyopathy.Impact of Demographic Features, Lifestyle, and Comorbidities on the Clinical Expression of Hypertrophic Cardiomyopathy.Hypertrophic cardiomyopathy: single gene disease or complex trait?Association between obstructive sleep apnea and comorbidities with periodontal disease in adults.
P2860
Q33829646-384A2D53-823F-44FE-A2BE-DD7FC0FD9072Q34401006-DE977C1C-D0FD-4340-8FF9-8BAA3242520BQ35672858-A7A6C7C3-B910-455E-B247-2F2A3C71B5C2Q35706912-212B9856-2CCC-48E4-BD3C-38181AF07E85Q37009096-E1EA41A7-757A-4FC0-B6C6-997662DA7F40Q37023645-679B1664-8AF6-42E7-AF1C-19C38498E61BQ37770111-1862F109-0B4D-4BF3-B406-677DB9F2E3E3Q38337000-B83FD7EC-6802-41BD-837F-26BA48249FC2Q39155008-527A1B2C-E908-4753-9BFD-AB4F5C379D2EQ42332738-97DC5FCB-E14D-4180-9BE3-1D0D8B699147Q47144202-B4B61454-514D-4147-87B2-E24E2C715C0CQ48113858-41E2ACAC-91B7-4584-ACCD-C59E94323331Q48319658-9E82954F-E2DD-4D47-B8E0-10F1AE102901Q49882490-F310724D-FF4A-4A83-BE51-1F17BCE5D270Q53463370-0B0BFEA3-5990-4D1F-92FE-5A3C087078FEQ55419378-786C0EE4-BA2A-4736-9AD1-8A6180DA76DC
P2860
High prevalence of abnormal nocturnal oximetry in patients with hypertrophic cardiomyopathy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
High prevalence of abnormal no ...... h hypertrophic cardiomyopathy.
@en
High prevalence of abnormal no ...... h hypertrophic cardiomyopathy.
@nl
type
label
High prevalence of abnormal no ...... h hypertrophic cardiomyopathy.
@en
High prevalence of abnormal no ...... h hypertrophic cardiomyopathy.
@nl
prefLabel
High prevalence of abnormal no ...... h hypertrophic cardiomyopathy.
@en
High prevalence of abnormal no ...... h hypertrophic cardiomyopathy.
@nl
P2093
P1476
High prevalence of abnormal no ...... h hypertrophic cardiomyopathy.
@en
P2093
A Jamil Tajik
Barbara L Sullivan
Bijoy K Khandheria
Farouk Mookadam
James M Parish
Mackram F Eleid
Marek Orban
Partho P Sengupta
Peter A Brady
Steve R Ommen
P304
P356
10.1016/J.JACC.2009.07.030
P407
P577
2009-11-01T00:00:00Z